Vir Biotechnology CEO George Scangos at annual J.P. Morgan Healthcare Conference

2:40 PM ET Tue, 14 Jan 2020

Vir Biotechnology CEO George Scangos speaks with CNBC from the 38th Annual J.P. Morgan Healthcare Conference.